Prevention study of hen's Egg Allergy with Low-allergenisity Egg powder

egg introduction for prevention of hen's egg allergy with ovomucoid-reduced egg powder : a randomised double-blind placebo-controlled trial - PEA-ORE

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-jRCTs041190089

Enrollment

200

Registered

2019-11-27

Start date

2019-11-27

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

eczema, atopic dermatitis, hen's egg allergy hen's egg allergy

Interventions

intake of heated hen's egg powder or ovomucoid reduced hen's egg powder from 6 months of age

egg powder

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 4-5 months of age baby who has ever diagnosed as atopic dermatitis or sufferd from itchy eczema

Exclusion criteria

Exclusion criteria: Baby who has a fatal immortal underlying disease, or whose ovomucoid specific IgE value is over 2.0 UA/ml

Design outcomes

Primary

Measure	Time frame
percentage of hen's egg allergy at 1 year of age	—

Secondary

Measure	Time frame
change of egg white and ovomucoid specific IgE value and ovomucoid specific IgG4 value	—

Contacts

Public ContactKaoru Okamoto

Fujita Health University Hosipital

oluaq@fujita-hu.ac.jp+81-562-95-2216

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026